Jiang, Hanyu
Li, Binrong
Zheng, Tianying
Qin, Yun
Wu, Yuanan
Wu, Zhenru
Ronot, Maxime
Chernyak, Victoria
Fowler, Kathryn J.
Bashir, Mustafa R.
Chen, Weixia
Wang, Yuan-Cheng
Ju, Shenghong
Song, Bin https://orcid.org/0000-0002-7269-2101
Funding for this research was provided by:
National Natural Science Foundation of China (82101997, U22A20343, 81830053, 82271978)
the China Postdoctoral Science Foundation (2023T160448)
the 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYGD22004)
Development Project of Hainan Provincial Clinical Medical Center
the Post-doctoral Station Development Project of Sanya (23CZ009)
Article History
Received: 29 July 2024
Revised: 25 October 2024
Accepted: 16 November 2024
First Online: 19 December 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Bin Song, M.D.
: All authors disclose no conflict of interest relevant to this work. Hanyu Jiang is a stock owner of Kanghong Technology Co., Ltd. Maxime Ronot received educational fees from Sirtex, Guerbet, Ipsen, Servier, GE Healthcare, Angiodynamics, and consulting fees (paid to the institution) from Quantum Surgical. Victoria Chernyak is a consultant for Bayer. Mustafa R. Bashir is principal investigator on grants paid to his institution from the National Cancer Institute, Siemens Healthineers, Bayer Healthcare, NGM Biopharmaceuticals, Madrigal Pharmaceuticals, Carmot Therapeutics, and Corcept Therapeutics.
: One co-author (Yuanan Wu, Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China) has significant statistical expertise.
: The requirement for informed consent was waived (retrospective design) by the Biomedical Ethics Review Committee of West China Hospital, Sichuan University.
: The study protocol was approved by the Biomedical Ethics Review Committee of West China Hospital, Sichuan University (Approval Numbers: 2022-1993).
: None.
: